{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "25849950", "DateCompleted": {"Year": "2016", "Month": "01", "Day": "30"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "04", "Day": "02"}], "ELocationID": ["10.3390/nu7042440"], "Language": ["eng"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "7", "Issue": "4", "PubDate": {"Year": "2015", "Month": "Apr", "Day": "02"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Hepatoprotective effect of herb formula KIOM2012H against nonalcoholic fatty liver disease.", "Pagination": {"StartPage": "2440", "EndPage": "2455", "MedlinePgn": "2440-55"}, "Abstract": {"AbstractText": ["Nonalcoholic fatty liver disease (NAFLD) is a hepatic ailment with a rapidly increasing incidence due to dietary hypernutrition and subsequent obesity. Fatty liver disease can lead to steatohepatitis, fibrosis, cirrhosis, and even cancer, which is associated with various complications. Discovering effective natural materials and herbs can provide alternative and complementary medical treatments to current chemical pharmaceuticals. To develop an effective natural agent for NAFLD, we formulated a combination of four herb mixtures (KIOM2012H) and observed lipid-lowering efficacy. The inhibitory effects of KIOM2012H on free fatty acid-induced lipid accumulation, triglyceride contents, and gene expressions were analyzed in HepG2 cells. Using high fat diet-fed mice, body weight changes, gross liver appearances, hepatic triglyceride contents, and gene expressions were evaluated. KIOM2012H dose-dependently inhibited lipid accumulation and gene expressions involved in lipogenesis and related regulators. Experimental animals also showed a decrease in body weight changes and lipid-associated physiological parameters. This study shows that KIOM2012H has an alleviating effect on fatty acid and lipid accumulation, and therefore can be applied for development of new therapeutic pharmaceuticals for treatment of NAFLD using natural products and herbs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, Yuseong-daero 1672, Yuseong-gu, Daejeon 305-811, Korea. uofaz@kiom.re.kr."}], "LastName": "Park", "ForeName": "Hwayong", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, Yuseong-daero 1672, Yuseong-gu, Daejeon 305-811, Korea. hyhhwang@kiom.re.kr."}], "LastName": "Hwang", "ForeName": "Youn-Hwan", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, Yuseong-daero 1672, Yuseong-gu, Daejeon 305-811, Korea. kite79@kiom.re.kr."}], "LastName": "Kim", "ForeName": "Dong-Gun", "Initials": "DG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, Yuseong-daero 1672, Yuseong-gu, Daejeon 305-811, Korea. lovejnj@kiom.re.kr."}], "LastName": "Jeon", "ForeName": "Jongwook", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "KM-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, Yuseong-daero 1672, Yuseong-gu, Daejeon 305-811, Korea. jyma@kiom.re.kr."}], "LastName": "Ma", "ForeName": "Jin Yeul", "Initials": "JY"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Fatty Acids, Nonesterified"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Triglycerides"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Diet, High-Fat"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["metabolism"], "DescriptorName": "Fatty Acids, Nonesterified"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hepatocytes"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipogenesis"}, {"QualifierName": ["drug effects", "physiopathology"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Non-alcoholic Fatty Liver Disease"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Preparations"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Triglycerides"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Adams L.A., Angulo P., Lindor K.D. Nonalcoholic fatty liver disease. Can. Med. Assoc. J. 2005;172:899\u2013905. doi: 10.1503/cmaj.045232.", "ArticleIdList": ["10.1503/cmaj.045232", "PMC554876", "15795412"]}, {"Citation": "Bedogni G., Nobili V., Tiribelli C. Epidemiology of fatty liver: An update. World J. Gastroenterol. 2014;20:9050\u20139054.", "ArticleIdList": ["PMC4112887", "25083078"]}, {"Citation": "Younossi Z.M., Stepanova M., Afendy M., Fang Y., Younossi Y., Mir H., Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin. Gastroenterol. Hepatol. 2011;9:524\u2013530. doi: 10.1016/j.cgh.2011.03.020.", "ArticleIdList": ["10.1016/j.cgh.2011.03.020", "21440669"]}, {"Citation": "Schwimmer J.B., Deutsch R., Kahen T., Lavine J.E., Stanley C., Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388\u20131393. doi: 10.1542/peds.2006-1212.", "ArticleIdList": ["10.1542/peds.2006-1212", "17015527"]}, {"Citation": "Than N.N., Newsome P.N. A concise review of non-alcoholic fatty liver disease. Atherosclerosis. 2015;239:192\u2013202. doi: 10.1016/j.atherosclerosis.2015.01.001.", "ArticleIdList": ["10.1016/j.atherosclerosis.2015.01.001", "25617860"]}, {"Citation": "Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Investig. 2005;115:1343\u20131351. doi: 10.1172/JCI23621.", "ArticleIdList": ["10.1172/JCI23621", "PMC1087172", "15864352"]}, {"Citation": "Tarantino G., Scopacasa F., Colao A., Capone D., Tarantino M., Grimaldi E., Savastano S. Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. World J. Gastroenterol. 2011;17:5280\u20135288. doi: 10.3748/wjg.v17.i48.5280.", "ArticleIdList": ["10.3748/wjg.v17.i48.5280", "PMC3247692", "22219597"]}, {"Citation": "Begriche K., Igoudjil A., Pessayre D., Fromenty B. Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it. Mitochondrion. 2006;6:1\u201328. doi: 10.1016/j.mito.2005.10.004.", "ArticleIdList": ["10.1016/j.mito.2005.10.004", "16406828"]}, {"Citation": "Tarantino G., Colao A., Capone D., Conca P., Tarantino M., Grimaldi E., Chianese D., Finelli C., Contaldo F., Scopacasa F., et al. Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. J. Biol. Regul. Homeost. Agents. 2011;25:47\u201356.", "ArticleIdList": ["21382273"]}, {"Citation": "Tamura S., Shimomura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J. Clin. Investig. 2005;115:1139\u20131142. doi: 10.1172/JCI24930.", "ArticleIdList": ["10.1172/JCI24930", "PMC1087181", "15864343"]}, {"Citation": "Awale S., Lu J., Kalauni S.K., Kurashima Y., Tezuka Y., Kadota S., Esumi H. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res. 2006;66:1751\u20131757. doi: 10.1158/0008-5472.CAN-05-3143.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-3143", "16452235"]}, {"Citation": "Hyam S.R., Lee I.A., Gu W., Kim K.A., Jeong J.J., Jang S.E., Han M.J., Kim D.H. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages. Eur. J. Pharmacol. 2013;708:21\u201329. doi: 10.1016/j.ejphar.2013.01.014.", "ArticleIdList": ["10.1016/j.ejphar.2013.01.014", "23375938"]}, {"Citation": "Tian X., Guo L.P., Hu X.L., Huang J., Fan Y.H., Ren T.S., Zhao Q.C. Protective effects of Arctium lappa L. roots against hydrogen peroxide-induced cell injury and potential mechanisms in SH-SY5Y cells. Cell. Mol. Neurobiol. 2014 doi: 10.1007/s10571-014-0129-7.", "ArticleIdList": ["10.1007/s10571-014-0129-7", "25352420"]}, {"Citation": "Shin Y.W., Bae E.A., Lee B., Lee S.H., Kim J.A., Kim Y.S., Kim D.H. In vitro and in vivo antiallergic effects of Glycyrrhiza glabra and its components. Planta Med. 2007;73:257\u2013261. doi: 10.1055/s-2007-967126.", "ArticleIdList": ["10.1055/s-2007-967126", "17327992"]}, {"Citation": "Seon M.R., Park S.Y., Kwon S.J., Lim S.S., Choi H.J., Park H., Lim D.Y., Kim J.S., Lee C.H., Kim J., et al. Hexane/ethanol extract of Glycyrrhiza uralensis and its active compound isoangustone A induce G1 cycle arrest in DU145 human prostate and 4T1 murine mammary cancer cells. J. Nutr. Biochem. 2012;23:85\u201392. doi: 10.1016/j.jnutbio.2010.11.010.", "ArticleIdList": ["10.1016/j.jnutbio.2010.11.010", "21429724"]}, {"Citation": "Adianti M., Aoki C., Komoto M., Deng L., Shoji I., Wahyuni T.S., Lusida M.I., Soetjipto, Fuchino H., Kawahara N., et al. Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species. Microbiol. Immunol. 2014;58:180\u2013187. doi: 10.1111/1348-0421.12127.", "ArticleIdList": ["10.1111/1348-0421.12127", "PMC7168410", "24397541"]}, {"Citation": "Fu Y., Chen J., Li Y.J., Zheng Y.F., Li P. Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice. Food Chem. 2013;141:1063\u20131071. doi: 10.1016/j.foodchem.2013.03.089.", "ArticleIdList": ["10.1016/j.foodchem.2013.03.089", "23790887"]}, {"Citation": "Lin A., Liu Y., Huang Y., Sun J., Wu Z., Zhang X., Ping Q. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Int. J. Pharm. 2008;359:247\u2013253. doi: 10.1016/j.ijpharm.2008.03.039.", "ArticleIdList": ["10.1016/j.ijpharm.2008.03.039", "18457928"]}, {"Citation": "Seo M.S., Hong S.W., Yeon S.H., Kim Y.M., Um K.A., Kim J.H., Kim H.J., Chang K.C., Park S.W. Magnolia officinalis attenuates free fatty acid-induced lipogenesis via AMPK phosphorylation in hepatocytes. J. Ethnopharmacol. 2014;157:140\u2013148. doi: 10.1016/j.jep.2014.09.031.", "ArticleIdList": ["10.1016/j.jep.2014.09.031", "25261688"]}, {"Citation": "Yin H.Q., Je Y.T., Kim Y.C., Shin Y.K., Sung S., Lee K., Jeong G.S., Kim Y.C., Lee B.H. Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c. J. Pharmacol. Sci. 2009;109:486\u2013495. doi: 10.1254/jphs.08182FP.", "ArticleIdList": ["10.1254/jphs.08182FP", "19372631"]}, {"Citation": "Lei L., Liu Y., Wang X., Jiao R., Ma K.Y., Li Y.M., Wang L., Man S.W., Sang S., Huang Y., et al. Plasma cholesterol-lowering activity of gingerol- and shogaol-enriched extract is mediated by increasing sterol excretion. J. Agric. Food Chem. 2014;62:10515\u201310521. doi: 10.1021/jf5043344.", "ArticleIdList": ["10.1021/jf5043344", "25290252"]}, {"Citation": "Nammi S., Sreemantula S., Roufogalis B.D. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin. Pharmacol. Toxicol. 2009;104:366\u2013373. doi: 10.1111/j.1742-7843.2008.00362.x.", "ArticleIdList": ["10.1111/j.1742-7843.2008.00362.x", "19413656"]}, {"Citation": "Fuhrman B., Rosenblat M., Hayek T., Coleman R., Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J. Nutr. 2000;130:1124\u20131131.", "ArticleIdList": ["10801908"]}, {"Citation": "Yim N.H., Cho W.K., Lee J.H., Jung Y.P., Yang H.J., Ma J.Y. HRT, Herbal formula, induces G(2)/M cell cycle arrest and apoptosis via suppressing Akt signaling pathway in human colon cancer cells. Evid. Based Complement. Altern. Med. 2012;2012:871893. doi: 10.1155/2012/871893.", "ArticleIdList": ["10.1155/2012/871893", "PMC3412102", "22899960"]}, {"Citation": "Greenspan P., Fowler S.D. Spectrofluorometric studies of the lipid probe, Nile Red. J. Lipid Res. 1985;26:781\u2013789.", "ArticleIdList": ["4031658"]}, {"Citation": "McMillian M.K., Grant E.R., Zhong Z., Parker J.B., Li L., Zivin R.A., Burczynski M.E., Johnson M.D. Nile Red binding to HepG2 cells: An improved assay for in vitro studies of hepatosteatosis. In Vitro Mol. Toxicol. 2001;14:177\u2013190. doi: 10.1089/109793301753407948.", "ArticleIdList": ["10.1089/109793301753407948", "11846991"]}, {"Citation": "Song K.H., Chiang J.Y. Glucagon and cAMP inhibit cholesterol 7\u03b1-hydroxylase (CYP7A1) gene expression in human hepatocytes: Discordant regulation of bile acid synthesis and gluconeogenesis. Hepatology. 2006;43:117\u2013125. doi: 10.1002/hep.20919.", "ArticleIdList": ["10.1002/hep.20919", "16323215"]}, {"Citation": "Erickson S.K. Nonalcoholic fatty liver disease. J. Lipid Res. 2009;50:412\u2013416. doi: 10.1194/jlr.R800089-JLR200.", "ArticleIdList": ["10.1194/jlr.R800089-JLR200", "PMC2674744", "19074370"]}, {"Citation": "Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Investig. 2004;114:147\u2013152. doi: 10.1172/JCI200422422.", "ArticleIdList": ["10.1172/JCI200422422", "PMC449757", "15254578"]}, {"Citation": "Grefhorst A., Elzinga B.M., Voshol P.J., Pl\u00f6sch T., Kok T., Bloks V.W., van der Sluijs F.H., Havekes L.M., Romijn J.A., Verkade H.J., et al. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 2002;277:34182\u201334190. doi: 10.1074/jbc.M204887200.", "ArticleIdList": ["10.1074/jbc.M204887200", "12097330"]}, {"Citation": "Greco D., Kotronen A., Westerbacka J., Puig O., Arkkila P., Kiviluoto T., Laitinen S., Kolak M., Fisher R.M., Hamsten A., et al. Gene expression in human NAFLD. Am. J. Physiol. Gastrointest. Liver Physiol. 2008;294:G1281\u2013G1287. doi: 10.1152/ajpgi.00074.2008.", "ArticleIdList": ["10.1152/ajpgi.00074.2008", "18388185"]}, {"Citation": "Miquilena-Colina M.E., Lima-Cabello E., S\u00e1nchez-Campos S., Garc\u00eda-Mediavilla M.V., Fern\u00e1ndez-Bermejo M., Lozano-Rodr\u00edguez T., Vargas-Castrill\u00f3n J., Buqu\u00e9 X., Ochoa B., Aspichueta P., et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut. 2011;60:1394\u20131402. doi: 10.1136/gut.2010.222844.", "ArticleIdList": ["10.1136/gut.2010.222844", "21270117"]}, {"Citation": "Zhou J., Febbraio M., Wada T., Zhai Y., Kuruba R., He J., Lee J.H., Khadem S., Ren S., Li S., et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPAR\u03b3 in promoting steatosis. Gastroenterology. 2008;134:556\u2013567. doi: 10.1053/j.gastro.2007.11.037.", "ArticleIdList": ["10.1053/j.gastro.2007.11.037", "18242221"]}, {"Citation": "Liang L., Zhao M., Xu Z., Yokoyama K.K., Li T. Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DF45)-like effector family. Biochem. J. 2003;370:195\u2013203. doi: 10.1042/BJ20020656.", "ArticleIdList": ["10.1042/BJ20020656", "PMC1223158", "12429024"]}, {"Citation": "Keller P., Petrie J.T., de Rose P., Gerin I., Wright W.S., Chiang S.H., Nielsen A.R., Fischer C.P., Pedersen B.K., MacDougald O.A. Fat-specific protein 27 regulates storage of triacylglycerol. J. Biol. Chem. 2008;283:14355\u201314365. doi: 10.1074/jbc.M708323200.", "ArticleIdList": ["10.1074/jbc.M708323200", "PMC2386939", "18334488"]}, {"Citation": "Puri V., Konda S., Ranjit S., Aouadi M., Chawla A., Chouinard M., Chakladar A., Czech M.P. Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J. Biol. Chem. 2007;282:34213\u201334218. doi: 10.1074/jbc.M707404200.", "ArticleIdList": ["10.1074/jbc.M707404200", "17884815"]}, {"Citation": "Van Rossum T.G., Vulto A.G., de Man R.A., Brouwer J.T., Schalm S.W. Review article: Glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment. Pharmacol. Ther. 1998;12:199\u2013205. doi: 10.1046/j.1365-2036.1998.00309.x.", "ArticleIdList": ["10.1046/j.1365-2036.1998.00309.x", "9570253"]}, {"Citation": "Okamoto M., Irii H., Tahara Y., Ishii H., Hirao A., Udagawa H., Hiramoto M., Yasuda K., Takanishi A., Shibata S., et al. Synthesis of a new [6]-gingerol analogue and its protective effect with respect to the development of metabolic syndrome in mice fed a high-fat diet. J. Med. Chem. 2011;54:6295\u20136304. doi: 10.1021/jm200662c.", "ArticleIdList": ["10.1021/jm200662c", "21851089"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "1", "Day": "15"}, {"Year": "2015", "Month": "3", "Day": "13"}, {"Year": "2015", "Month": "3", "Day": "25"}, {"Year": "2015", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["25849950", "PMC4425153", "10.3390/nu7042440", "nu7042440"]}}], "PubmedBookArticle": []}